DEREK NORMAN

Derek Norman serves as a distinguished Vice President at Leaps by Bayer, the strategic impact investment unit of Bayer AG. In this pivotal role, Mr. Norman is instrumental in identifying, evaluating, and investing in groundbreaking companies poised to tackle some of humanity's most pressing challenges. Leaps by Bayer operates with a bold mandate: to invest in paradigm-shifting technologies and solutions that can make a profound positive impact on health and agriculture globally.

Mr. Norman's investment focus aligns directly with Leaps by Bayer's ambitious mission, spanning critical sectors such as biotechnology, digital health, sustainable agriculture, and novel therapeutic platforms. He seeks out innovative ventures that are developing solutions to cure or prevent diseases, enhance food security, and promote environmental sustainability. His work involves deep engagement with scientific founders and entrepreneurial teams, providing not just capital but also strategic guidance to help these companies scale their revolutionary ideas.

Prior to joining Leaps by Bayer, Derek Norman built a robust career foundation in venture capital and corporate strategy within the life sciences sector. He previously held a significant role at Merck Ventures (M Ventures), where he was involved in numerous investments across various stages of company development. This experience honed his expertise in evaluating complex scientific propositions and understanding the commercialization pathways for cutting-edge technologies. His background also includes roles in corporate development, further solidifying his understanding of strategic partnerships and business growth within large pharmaceutical and biotech organizations. Academically, Mr. Norman holds a Ph.D., providing him with a deep scientific acumen that is invaluable in assessing the technical merits and potential of early-stage innovations.

While specific individual investments are often attributed to the Leaps by Bayer fund as a whole, Mr. Norman plays a crucial role in shaping the portfolio. He contributes to investments in companies developing next-generation gene therapies, precision agriculture tools, and sustainable bio-solutions, all aimed at creating a healthier, more sustainable future. His strategic vision and scientific insight are key drivers in Leaps by Bayer's commitment to fostering radical innovation. Through his dedication, Derek Norman continues to champion companies that promise to deliver transformative breakthroughs, embodying Leaps by Bayer's philosophy of "leaping" over current limitations to achieve a better world.